{
    "title": "Bristol-Myers tops 3rd-qtr estimates as sales of top drugs sizzle",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2806500/Bristol-Myers-tops-3rd-qtr-estimates-sales-drugs-sizzle.html",
    "date": "2014-10-24",
    "keywords": [
        "cancer",
        "share",
        "lung",
        "analyst",
        "percent",
        "pd1",
        "october",
        "ransdell",
        "co",
        "thirdquarter",
        "stock",
        "tax",
        "rate",
        "inhibitor",
        "approval",
        "meeting",
        "chicago",
        "treatment",
        "street",
        "revenue",
        "profit",
        "gmt",
        "email",
        "piersonoct",
        "blood",
        "arthritis",
        "drugmaker",
        "friday",
        "quarter",
        "yearearlier",
        "company",
        "estimate",
        "poll",
        "thomson",
        "year",
        "agosanford",
        "tim",
        "anderson",
        "material",
        "reportlater",
        "attention",
        "immunooncology",
        "review",
        "system",
        "inc",
        "roche",
        "ag",
        "astrazeneca",
        "plc",
        "class",
        "japan",
        "july",
        "melanoma",
        "process",
        "drug",
        "form",
        "trial",
        "use",
        "opdivo",
        "failedoverall",
        "potential",
        "capital",
        "arfaei",
        "fridayhe",
        "range",
        "symposium",
        "thoracic",
        "oncologyarfaei",
        "pembrolizumab",
        "month",
        "sale",
        "partner",
        "beat",
        "forecast",
        "reporting",
        "pierson",
        "york",
        "editing",
        "jeffrey",
        "benkoe"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}